awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33750604-5A954E44-0C70-43C0-9B6F-DC85306B84B1
Q33750604-5A954E44-0C70-43C0-9B6F-DC85306B84B1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33750604-5A954E44-0C70-43C0-9B6F-DC85306B84B1
Switching From Donepezil to Rivastigmine Is Well Tolerated: Results of an Open-Label Safety and Tolerability Study.
P2860
Q33750604-5A954E44-0C70-43C0-9B6F-DC85306B84B1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33750604-5A954E44-0C70-43C0-9B6F-DC85306B84B1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b405504d67f08ca20f3042e2c1b7948f19981b43
P2860
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.